title: Coagulopathy in a patient with X-linked hyper-IgM syndrome who developed Kaposi's sarcoma.
authors.forename: Masayuki
authors.initials: M
authors.lastname: Nagasawa
authors.forename: Sukeyuki
authors.initials: S
authors.lastname: Itoh
authors.forename: Yasuyuki
authors.initials: Y
authors.lastname: Sawada
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Morio
authors.forename: Shigeaki
authors.initials: S
authors.lastname: Nonoyama
authors.forename: Shuki
authors.initials: S
authors.lastname: Mizutani
mesh_terms: D000293:Adolescent; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002066:Busulfan / Q000008:administration & dosage; D041321:Chromosomes, Human, X; D003520:Cyclophosphamide / Q000008:administration & dosage; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood*; D007153:Immunologic Deficiency Syndromes / Q000150:complications* / Q000235:genetics / Q000276:immunology; D008297:Male; D012514:Sarcoma, Kaposi / Q000188:drug therapy / Q000209:etiology*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D007075:Immunoglobulin M; D003520:Cyclophosphamide; D002066:Busulfan